Immunicum AB logo

IMMU - Immunicum AB Share Price

SEK6.33 -0.2  -2.3%

Last Trade - 13/09/19

Sector
Healthcare
Size
Micro Cap
Market Cap £48.6m
Enterprise Value £18.4m
Revenue £n/a
Position in Universe 878th / 1473
Bullish
Bearish
Unlock IMMU Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

IMMU Revenue Unlock IMMU Revenue

Net Income

IMMU Net Income Unlock IMMU Revenue

Normalised EPS

IMMU Normalised EPS Unlock IMMU Revenue

PE Ratio Range

IMMU PE Ratio Range Unlock IMMU Revenue

Dividend Yield Range

IMMU Dividend Yield Range Unlock IMMU Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IMMU EPS Forecasts Unlock IMMU Revenue
Profile Summary

Immunicum AB is a Sweden-based company principally engaged in the biopharmaceutical sector. The Company develops immunotherapy for therapeutic treatment of cancer and infectious diseases. The Company uses therapeutic vaccines to treat an already existing disease and is thus given to the already sick patients; therapeutic cancer vaccines administered to patients in order to delay or stop tumor cell growth, shrink tumors, prevent relapse, or to kill cancer cells that could not be eliminated with other treatments. The Company has several technology platforms, such as The Combig, Intuvax@, Subcuvax@ and The CD70, among others. The Company has several projects which are related to kidney cancer and liver cancer, among others.

Directors
Last Annual December 31st, 2018
Last Interim June 30th, 2019
Public Since April 22, 2013
No. of Shareholders: n/a
No. of Employees: 11
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 92,257,531
Free Float (0.0%)
Eligible for
ISAs
SIPPs
IMMU Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for IMMU
Upcoming Events for IMMU
Tuesday 5th November, 2019 Estimate
Q3 2019 Immunicum AB Earnings Release
Thursday 13th February, 2020 Estimate
Q4 2019 Immunicum AB Earnings Release
Similar to IMMU
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.